#16
|
||||
|
||||
Цитата:
1: Volgin AR, Demina IuV. [Experience of using bacterial lysate IRS 19 for the prophylaxis of the diseases of respiratory organs in organized groups] Zh Mikrobiol Epidemiol Immunobiol. 2005 May-Jun;(3): 82-4. Russian. PMID: 16028523 2: Gunchikov MV, Vinnikov AK. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts] Vestn Otorinolaringol. 2001;(1): 40. Russian. No abstract available. PMID: 11247247 3: Luchikhin LA, Beliakova LV, Gurov AV. [Prevention and treatment of upper respiratory tract infections with IRS-19 and polydex with phenylephrine] Vestn Otorinolaringol. 2000;(4): 54-7. Russian. No abstract available. PMID: 11011582 4: Nowak D, Prozynski M, Pietras T, Stolarek R, Mazerant P, Leder M. Effect of bacterial extract, IRS-19, on the concentration of hydrogen peroxide and myeloperoxidase activity in nasal washings of patients with chronic bronchitis. Arch Immunol Ther Exp (Warsz). 1997; 45 (1): 67-72. PMID: 9090443 5: Kaspar P, Petro W. [Inhalative immunostimulation in patients with chronic bronchitis] Z Hautkr. 1988; 63 Suppl 4: 64-6. German. PMID: 3075383 [PubMed - indexed for MEDLINE] Вот, собственно говоря, и вся "научная база" этого препарата. |